
ZetaGen Therapeutics
Developer of a small molecule-based osteoinductive technology designed to suspend cancer, inhibit pain and regenerate bone. The company's technology can transform the treatment of bone-related injurie...
Valuation
$0
Share Price
N/A
Total Raised
$52.5M
Last Round
N/A